Showing results (1-10 of 294) with videos related to
Sort By:
Pageof 30
Cells, Tissues, Organs|June 26, 2007
Mesenchymal to epithelial transition in development and diseaseChristine L Chaffer, Erik W Thompson, Elizabeth D WilliamsBMC Cancer|March 8, 2006
PPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinomaChristine L Chaffer, David M Thomas, Erik W Thompson, et al.Differentiation; Research in Biological Diversity|August 19, 2007
Aberrant fibroblast growth factor receptor signaling in bladder and other cancersChristine L Chaffer, Bonnie Dopheide, Pierre Savagner, et al.Cancer Research|December 6, 2006
Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2Christine L Chaffer, Janelle P Brennan, John L Slavin, et al.Clinical & Experimental Metastasis|August 9, 2005
Upregulated MT1-MMP/TIMP-2 axis in the TSU-Pr1-B1/B2 model of metastatic progression in transitional cell carcinoma of the bladderChristine L Chaffer, Bonnie Dopheide, Daniel R McCulloch, et al.Clinical & Experimental Metastasis|June 21, 2008
EMT and MET in carcinoma--clinical observations, regulatory pathways and new modelsErik W Thompson, Elizabeth D WilliamsThe International Journal of Biochemistry & Cell Biology|October 12, 2004
Interleukin-6 is a potent inducer of S100P, which is up-regulated in androgen-refractory and metastatic prostate cancerAnnet Hammacher, Erik W Thompson, Elizabeth D WilliamsCells, Tissues, Organs|April 2, 2010
Disparate companions: tissue engineering meets cancer researchDaniel J Tilkorn, Zerina Lokmic, Christine L Chaffer, et al.Frontiers in Bioscience (Landmark Edition)|October 6, 2019
Applications of RNA from circulating tumor cellsSara Hassan, Tony Blick, Elizabeth D Williams, et al.Nature Reviews. Cancer|November 1, 2019
Controversies around epithelial-mesenchymal plasticity in cancer metastasisElizabeth D Williams, Dingcheng Gao, Andrew Redfern, et al.Pageof 30